Glycosphingolipids and Drug Resistance.
From: Department of Experimental Therapeutics, The John Wayne Cancer Institute at Saint John’s Health Center, 2200 Santa Monica Blvd., Santa Monica, CA 90404, USA.
Biochimica et biophysica acta
- Publish Date: Dec 2006
- ISSN: 0006-3002
- Volume: 1758
- Issue: 12
- Pages: 2096-103
- Medium: Print
- Language: English
- Citation (JAMA): Gouaze-Andersson Valerie, Cabot Myles C, et al. Glycosphingolipids and Drug Resistance.. Biochim. Biophys. Acta Dec 2006;1758:2096-103
Abstract
Drug resistance, an all too frequent characteristic of cancer, represents a serious barrier to successful treatment. Although many resistance mechanisms have been described, those that involve membrane-resident proteins belonging to the ABC (ATP binding cassette) transporter superfamily are of particular interest. In addition to cancer, the ABC transporter proteins are active in diseases such as malaria and leishmaniasis. A recent renaissance in lipid metabolism, specifically ceramide and sphingolipids, has fueled research and provided insight into the role of glycosphingolipids in multidrug resistance. This article reviews current knowledge on ceramide, glucosylceramide synthase and cerebrosides, and the relationship of these lipids to cellular response to anticancer agents.
Mesh Headings (Keywords): ATP-Binding Cassette Transporters, Animals, Drug Resistance, Glycosphingolipids, Humans, Lipids, Neoplasms
Check for Full Text / PubMed Unique Identifier (PMID): 17010304
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.